- Previous close
0.0260 - Open
0.0250 - Bid 0.0250 x 3000000
- Ask 0.0260 x 10519300
- Day's range
0.0250 - 0.0250 - 52-week range
0.0150 - 0.0293 - Volume
32,097 - Avg. Volume
402,941 - Market cap (intra-day)
13.815M - Beta (5Y monthly) -0.04
- PE ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings date 29 Nov 2024
- Forward dividend & yield --
- Ex-dividend date --
- 1y target est
--
TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, Eastern Europe, the Middle East/North Africa, and internationally. The company offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020. TruScreen Group Limited was incorporated in 2013 and is headquartered in Auckland, New Zealand.
truscreen.com--
Full-time employees
31 March
Fiscal year ends
Healthcare
Sector
Medical Devices
Industry
Recent news: TRU.NZ
View more
Performance overview: TRU.NZ
Trailing total returns as of 11/12/2024, which may include dividends or other distributions. Benchmark is
.YTD return
1-year return
3-year return
5-year return
Compare to: TRU.NZ
Select to analyse similar companies using key performance metrics; select up to four stocks.
Statistics: TRU.NZ
View moreValuation measures
Market cap
14.37M
Enterprise value
13.00M
Trailing P/E
--
Forward P/E
--
PEG ratio (5-yr expected)
--
Price/sales (ttm)
5.77
Price/book (mrq)
6.98
Enterprise value/revenue
6.03
Enterprise value/EBITDA
--
Financial highlights
Profitability and income statement
Profit margin
-78.80%
Return on assets (ttm)
-30.85%
Return on equity (ttm)
-71.03%
Revenue (ttm)
2.6M
Net income avi to common (ttm)
-2.05M
Diluted EPS (ttm)
-0.0000
Balance sheet and cash flow
Total cash (mrq)
2.73M
Total debt/equity (mrq)
--
Levered free cash flow (ttm)
-1.18M